Centaur Pharmaceuticals centaurpharma.com


Public lists: Pharma Startups (4732)

Centaur Pharmaceuticals developed a class of small molecule pharmaceutical compounds for the treatment of neurodegenerative and inflammatory diseases such as acute stroke, dementia, rheumatoid arthritis, myocardial ischemia and Parkinson's disease. Renovis is a biopharmaceutical company with a primary focus on the discovery, development and commercialization of drugs to treat neurological diseases and disorders. Renovis acquired Centaur Pharmaceuticals, Inc. in December 2002.

Centaur Pharmaceuticals developed a class of small molecule pharmaceutical compounds for the treatment of neurodegenerative and inflammatory diseases such as acute stroke, dementia, rheumatoid arthritis, myocardial ischemia and Parkinson's disease. R...Show all

Company (Acquired)

Phone: 408-822-1600

Fax:

1220 Memorex Drive
Opp. Grand Hyatt, Vakola
Santa Clara, 95050
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Centaur Pharmaceuticals $55.8M Dec 5, 2002
See all 58 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Centaur Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Cycad GroupVenture CapitalCarpinteria, California, United StatesOther Investors
SIDBI VentureVenture CapitalMumbai, IndiaOther Investors
SME Growth FundOther Investors
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 58 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Process for the preparation of eszopiclone Nov 06, 2007 Aug 31, 2010 Patent